Systemic Lupus Erythromatosis

This test helps to verify if what the patient is presenting is lupus and not another disease. It also helps to determine prognosis or progression of disease, to monitor the severity of the disease, the efficacy of treatment, medication-related side effects, and in making treatment recommendations and to adjust for changing symptoms. Some of the screening tests are Antinuclear antibody (ANA) autoantibodies, FBC, ESR, Complement 3,4, cReactive protein, CENP, RF, and some antibody screenings.